Aemetis (AMTX) AI Stock Analysis

• Market Cap: $157.47M
• Dividend Yield: N/A
• Average Volume (3M): 1.02M
• Price to Earnings (P/E): ―
• Beta (1Y): 2.55
• Revenue Growth: -19.77%
• EPS Growth: -47.88%
• Country: US
• Employees: 223
• Sector: Basic Materials
• Sector Strength: 60
• Industry: Oil & Gas Refining & Marketing
• EPS (TTM): -0.41
• Shares Outstanding: 63,240,955
• 10 Day Avg. Volume: 840,893
• 30 Day Avg. Volume: 1,015,245
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: 3.94
• Enterprise Value/Revenue: 2.77
• Enterprise Value/Gross Profit: -93.98
• Enterprise Value/Ebitda: -14.46
• 1Y Price Target: $7.00
• Price Target Upside: 181.12% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 4

• Rating: 43 Neutral
• Price Target: $2.50 ▲(0.40% Upside)

Aemetis faces significant financial challenges, with negative profitability and high leverage being the most critical issues. While there are positive developments from the earnings call, such as increased revenues and strategic expansions, the financial instability and bearish technical indicators weigh heavily on the overall score. The negative valuation metrics further underscore the risks associated with the stock.

Positive Factors

Financial Growth Plan

Aemetis has a strong 5-year financial plan aiming to reach $1 billion in revenue by 2026, indicating confidence in significant growth potential.

Sustainable Investments

Approval for $200 million of EB-5 program investment for multiple sustainable projects, including the Riverbank SAF production plant and the dairy RNG project.

Negative Factors

Fiscal Revenue

Aemetis reported its fiscal Q4 2024 revenue at $47 million, which was significantly lower than the previous year and below both analyst estimates and consensus expectations.

Revenue Performance

Q1 revenue was $43 million, compared to estimates of $50 million and consensus of $59 million, indicating weaker than expected performance.

Aemetis Business Overview & Revenue Model

Company Description

Aemetis, Inc. is a renewable fuels and biochemicals company focused on the production of advanced biofuels and renewable chemicals. The company operates in the renewable energy sector, primarily focusing on the conversion of agricultural waste into sustainable fuel alternatives. Aemetis produces products such as ethanol, biodiesel, and renewable diesel from various feedstocks, including corn and other agricultural residues, and aims to provide solutions that reduce greenhouse gas emissions and promote sustainability.

How the Company Makes Money

Aemetis generates revenue through multiple streams, primarily by selling its renewable fuels and chemicals to various markets. The company's key revenue streams include the production and sale of ethanol, biodiesel, and renewable diesel, which are sold to fuel distributors and other end-users. Additionally, Aemetis has entered into partnerships and agreements that enhance its production capabilities and expand its market reach, including collaborations with agricultural producers and other companies within the renewable energy sector. The company also benefits from government incentives and subsidies aimed at promoting renewable energy sources, which can contribute significantly to its profitability. Furthermore, Aemetis is involved in carbon capture and sequestration projects, which may provide additional revenue opportunities through carbon credits and environmental credits.

Aemetis Financial Statement Overview

Summary

Aemetis is facing significant financial challenges across all verticals. The company is struggling with profitability, high leverage, and negative cash flows. Immediate strategic adjustments are necessary to improve the financial health and ensure long-term sustainability.

Income Statement

Aemetis has faced significant challenges in profitability and revenue growth. The TTM gross profit margin remains negative, indicating struggles with cost management. There is a notable negative trend in net profit margin and EBIT margin, highlighting ongoing losses. Revenue growth has been inconsistent, with recent periods showing a decline.

Balance Sheet

The balance sheet shows a high debt burden with negative stockholders' equity, reflecting financial instability and potential solvency concerns. The debt-to-equity ratio is unfavorable due to negative equity, and the equity ratio is negative, demonstrating an over-leveraged position.

Cash Flow

Cash flow metrics indicate severe challenges in generating positive cash flow. The TTM operating cash flow is negative, and free cash flow remains negative, highlighting liquidity issues. The free cash flow to net income ratio is concerning, suggesting poor cash conversion.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	223.57M	267.64M	186.72M	256.51M	211.95M	165.56M
Gross Profit	-6.60M	-580.00K	2.02M	-5.54M	7.94M	11.03M
EBITDA	-42.88M	-37.13M	-34.84M	-62.17M	-15.82M	-5.08M
Net Income	-82.06M	-87.54M	-46.42M	-107.76M	-47.15M	-36.66M
Balance Sheet
Total Assets	240.02M	259.30M	243.41M	207.11M	160.83M	125.14M
Cash, Cash Equivalents and Short-Term Investments	1.65M	898.00K	2.67M	4.31M	7.75M	592.00K
Total Debt	478.58M	338.06M	417.34M	248.43M	22.78M	59.52M
Total Liabilities	529.27M	523.23M	460.38M	408.97M	281.07M	309.88M
Stockholders Equity	-289.25M	-263.93M	-216.98M	-201.85M	-120.24M	-184.74M
Cash Flow
Free Cash Flow	-39.76M	-53.18M	-19.29M	-62.02M	-47.30M	-16.86M
Operating Cash Flow	-23.13M	-32.93M	13.82M	-22.87M	-20.65M	2.48M
Investing Cash Flow	-13.15M	-14.15M	-23.69M	-31.31M	-22.89M	-17.31M
Financing Cash Flow	37.14M	44.62M	9.09M	53.63M	50.70M	14.78M

Aemetis Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 2.49
• 50DMA: Negative
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AMTX, the sentiment is Negative. The current price of 2.49 is below the 20-day moving average (MA) of 2.81, below the 50-day MA of 2.65, and above the 200-day MA of 2.38, indicating a neutral trend. The MACD of -0.05 indicates Positive momentum. The RSI at 41.54 is Neutral, neither overbought nor oversold. The STOCH value of 52.15 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AMTX.

Aemetis Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
DINO	70 Outperform	$8.38B	35.13	-0.93%	4.46%	-14.58%	-107.50%
Sector *	61 Neutral	$10.10B	6.09	1.13%	3.02%	2.99%	-45.49%
CLNE	56 Neutral	$526.29M	―	-30.98%	―	4.92%	-156.72%
PARR	52 Neutral	$1.47B	3.02	-1.59%	―	-13.09%	-103.24%
CVI	51 Neutral	$2.72B	268.82	-50.65%	10.20%	-15.98%	-160.88%
DK	47 Neutral	$1.31B	―	-200.75%	4.69%	-29.94%	-723.41%
AMTX	43 Neutral	$157.47M	―	37.38%	―	-19.77%	-47.88%

Aemetis Corporate Events

Aemetis Announces Director Elections and Key Approvals

At its Annual Meeting of Stockholders on May 14, 2025, Aemetis, Inc. announced the election of Eric A. McAfee and Francis P. Barton as Class I directors, who will serve until the 2028 annual meeting. Additionally, the appointment of RSM US LLP as the independent registered public accounting firm for 2025 was ratified, and the compensation of the Company’s Named Executive Officers was approved on an advisory basis with 83% support.

The most recent analyst rating on (AMTX) stock is a Buy with a $28.00 price target. To see the full list of analyst forecasts on Aemetis stock, see the AMTX Stock Forecast page.